Breaking News Instant updates and real-time market news.

NEOS

Neos Therapeutics

$1.25 /

-0.135 (-9.75%)

07:48
03/13/20
03/13
07:48
03/13/20
07:48

Neos Therapeutics reports Q4 EPS (7c), consensus (3c)

Reports Q4 revenue $16.8M, consensus $20.57M. "We made tremendous strides in 2019, following the reset of our commercial strategy for our ADHD portfolio, which resulted in an improvement to the financial foundation of the company. In particular, we realized a 29% increase in net revenues for the full year of 2019 compared to 2018 and through our focus on operational productivity and expense management, we reduced our operating loss by approximately $33 million compared to 2018. During the year, we established and rapidly grew our proprietary Neos RxConnect patient support program to approximately 500 pharmacies. As we look forward, we are confident in the outlook for 2020 and beyond," said Jerry McLaughlin, president and chief executive officer. "We are also extremely pleased to now have top-line results from the NT0502 Phase 1 pilot pharmacokinetic study, and we plan to initiate an ascending dose study in the second half of the year. We believe NT0502 has the potential to address a significantly underserved patient population of individuals struggling with chronic sialorrhea, otherwise known as excessive drooling, across numerous debilitating CNS disorders."

  • 13

    Mar

NEOS Neos Therapeutics
$1.25 /

-0.135 (-9.75%)

06/12/19 Cantor Fitzgerald
Neos Therapeutics price target lowered to $10 from $20 at Cantor Fitzgerald

TODAY'S FREE FLY STORIES

Initiation
NMI Holdings initiated with a Buy at Citi » 07:22
08/14/20
08/14
07:22
08/14/20
07:22
NMIH

NMI Holdings

/

+

Citi analyst Arren…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NMIH NMI Holdings
/

+

NMIH NMI Holdings
/

+

06:39 Today Citi
NMI Holdings initiated with a Buy at Citi
07/20/20 Susquehanna
NMI Holdings consensus loss ratio estimates too high. says Susquehanna
07/15/20 JPMorgan
NMI upgraded to Overweight on capital position at JPMorgan
07/15/20 JPMorgan
NMI Holdings upgraded to Overweight from Neutral at JPMorgan
NMIH NMI Holdings
/

+

  • 04
    Jun
NMIH NMI Holdings
/

+

NMIH NMI Holdings
/

+

Downgrade
New Relic downgraded to Hold from Buy at Argus » 07:22
08/14/20
08/14
07:22
08/14/20
07:22
NEWR

New Relic

$55.78 /

+1.25 (+2.29%)

Argus analyst Joseph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NEWR New Relic
$55.78 /

+1.25 (+2.29%)

NEWR New Relic
$55.78 /

+1.25 (+2.29%)

07:13 Today Argus
New Relic downgraded to Hold from Buy at Argus
08/05/20 UBS
New Relic sales turnaround taking longer than expected, says UBS
08/05/20 JPMorgan
New Relic downgraded to Neutral on strategy change at JPMorgan
08/05/20 JPMorgan
New Relic downgraded to Neutral from Overweight at JPMorgan
NEWR New Relic
$55.78 /

+1.25 (+2.29%)

NEWR New Relic
$55.78 /

+1.25 (+2.29%)

Recommendations
Wells Fargo prefers Target to Walmart ahead of earnings next week » 07:21
08/14/20
08/14
07:21
08/14/20
07:21
TGT

Target

$134.82 /

+0.21 (+0.16%)

, WMT

Walmart

$131.83 /

+1.04 (+0.80%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TGT Target
$134.82 /

+0.21 (+0.16%)

WMT Walmart
$131.83 /

+1.04 (+0.80%)

TGT Target
$134.82 /

+0.21 (+0.16%)

06:46 Today DA Davidson
Target initiated with a Buy at DA Davidson
08/13/20 Baird
Target price target raised to $150 from $135 at Baird
08/12/20 JPMorgan
JPMorgan adds Target to Analyst Focus List, raises price target to $154
08/11/20 Morgan Stanley
Target price target raised to $135 from $120 at Morgan Stanley
WMT Walmart
$131.83 /

+1.04 (+0.80%)

06:46 Today DA Davidson
Walmart initiated with a Buy at DA Davidson
07/30/20
Fly Intel: Top five analyst initiations
07/30/20 MKM Partners
BJ's Wholesale initiated with a Sell at MKM Partners
07/30/20 MKM Partners
Target initiated with a Sell at MKM Partners
TGT Target
$134.82 /

+0.21 (+0.16%)

WMT Walmart
$131.83 /

+1.04 (+0.80%)

TGT Target
$134.82 /

+0.21 (+0.16%)

WMT Walmart
$131.83 /

+1.04 (+0.80%)

TGT Target
$134.82 /

+0.21 (+0.16%)

WMT Walmart
$131.83 /

+1.04 (+0.80%)

TGT Target
$134.82 /

+0.21 (+0.16%)

WMT Walmart
$131.83 /

+1.04 (+0.80%)

Initiation
NetEase initiated with a Buy at Daiwa » 07:18
08/14/20
08/14
07:18
08/14/20
07:18
NTES

NetEase

$464.95 /

-9.21 (-1.94%)

Daiwa analyst John Choi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTES NetEase
$464.95 /

-9.21 (-1.94%)

NTES NetEase
$464.95 /

-9.21 (-1.94%)

07:13 Today Benchmark
NetEase price target raised to $520 from $435 at Benchmark
07/27/20 Barclays
NetEase price target raised to $500 from $450 at Barclays
07/21/20 Citi
NetEase price target raised to $543 from $453 at Citi
06/12/20
Fly Intel: Top five analyst initiations
NTES NetEase
$464.95 /

-9.21 (-1.94%)

NTES NetEase
$464.95 /

-9.21 (-1.94%)

NTES NetEase
$464.95 /

-9.21 (-1.94%)

NTES NetEase
$464.95 /

-9.21 (-1.94%)

Earnings
Bio-Path Holdings reports Q2 EPS (55c), one est. (96c) » 07:18
08/14/20
08/14
07:18
08/14/20
07:18
BPTH

Bio-Path Holdings

$5.53 /

+0.79 (+16.67%)

"Despite the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BPTH Bio-Path Holdings
$5.53 /

+0.79 (+16.67%)

BPTH Bio-Path Holdings
$5.53 /

+0.79 (+16.67%)

05/18/20 H.C. Wainwright
Bio-Path Holdings price target lowered to $18 from $25 at H.C. Wainwright
BPTH Bio-Path Holdings
$5.53 /

+0.79 (+16.67%)

Hot Stocks
Apollo Infrastructure Funds announces strategic investment in US Wind » 07:16
08/14/20
08/14
07:16
08/14/20
07:16
APO

Apollo Global

$48.45 /

+0.37 (+0.77%)

Apollo Global Management…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APO Apollo Global
$48.45 /

+0.37 (+0.77%)

APO Apollo Global
$48.45 /

+0.37 (+0.77%)

07/01/20 Barclays
Apollo Global price target raised to $51 from $44 at Barclays
06/30/20
Fly Intel: Top five analyst downgrades
06/30/20 Goldman Sachs
Apollo Global downgraded to Buy from Conviction Buy at Goldman Sachs
06/08/20 Citi
Citi downgrades Alternative Asset Managers to Market Weight, lowers four ratings
APO Apollo Global
$48.45 /

+0.37 (+0.77%)

  • 26
    Nov
APO Apollo Global
$48.45 /

+0.37 (+0.77%)

APO Apollo Global
$48.45 /

+0.37 (+0.77%)

APO Apollo Global
$48.45 /

+0.37 (+0.77%)

Downgrade
Meredith downgraded to Hold from Buy at Benchmark » 07:16
08/14/20
08/14
07:16
08/14/20
07:16
MDP

Meredith

$16.06 /

+0.175 (+1.10%)

Benchmark analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MDP Meredith
$16.06 /

+0.175 (+1.10%)

MDP Meredith
$16.06 /

+0.175 (+1.10%)

06:19 Today Benchmark
Meredith downgraded to Hold from Buy at Benchmark
06/29/20 Citi
Meredith price target lowered to $18 from $20 at Citi
06/04/20 Citi
Meredith price target raised to $20 from $16 at Citi
03/06/20 Benchmark
Meredith dividend looks 'very safe,' says Benchmark
MDP Meredith
$16.06 /

+0.175 (+1.10%)

MDP Meredith
$16.06 /

+0.175 (+1.10%)

MDP Meredith
$16.06 /

+0.175 (+1.10%)

Initiation
Sea Limited initiated with an Add at CIMB » 07:15
08/14/20
08/14
07:15
08/14/20
07:15
SE

Sea Limited

$127.95 /

+1.15 (+0.91%)

CIMB analyst Ngoh Yi Sin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SE Sea Limited
$127.95 /

+1.15 (+0.91%)

SE Sea Limited
$127.95 /

+1.15 (+0.91%)

08/13/20 Macquarie
Sea Limited initiated with an Underperform at Macquarie
07/08/20 Citi
Sea Limited price target raised to $138 from $79 at Citi
06/30/20 Stephens
Sea Limited initiated with an Overweight at Stephens
06/30/20 Stephens
Sea Limited initiated with an Overweight at Stephens
SE Sea Limited
$127.95 /

+1.15 (+0.91%)

SE Sea Limited
$127.95 /

+1.15 (+0.91%)

SE Sea Limited
$127.95 /

+1.15 (+0.91%)

Recommendations
FedEx price target raised to $221 from $179 at Wells Fargo » 07:15
08/14/20
08/14
07:15
08/14/20
07:15
FDX

FedEx

$203.88 /

+2.06 (+1.02%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FDX FedEx
$203.88 /

+2.06 (+1.02%)

FDX FedEx
$203.88 /

+2.06 (+1.02%)

08/13/20 Citi
FedEx still has 'meaningful upside,' says Citi
08/12/20 UBS
FedEx price target raised to $218 from $181 at UBS
08/10/20
Fly Intel: Top five analyst upgrades
08/10/20 Bernstein
FedEx upgraded to Outperform from at Bernstein
FDX FedEx
$203.88 /

+2.06 (+1.02%)

FDX FedEx
$203.88 /

+2.06 (+1.02%)

FDX FedEx
$203.88 /

+2.06 (+1.02%)

FDX FedEx
$203.88 /

+2.06 (+1.02%)

Downgrade
Vroom downgraded to Hold from Buy at Benchmark on revenue reset » 07:14
08/14/20
08/14
07:14
08/14/20
07:14
VRM

Vroom

$56.34 /

-13 (-18.75%)

Benchmark analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRM Vroom
$56.34 /

-13 (-18.75%)

VRM Vroom
$56.34 /

-13 (-18.75%)

06:20 Today Benchmark
Vroom downgraded to Hold from Buy at Benchmark
08/13/20 Wells Fargo
Vroom price target raised to $76 from $65 at Wells Fargo
08/13/20 Wedbush
Vroom price target raised to $80 from $75 at Wedbush
08/13/20 Baird
Baird would be buyers of Vroom amid post-earnings weakness
VRM Vroom
$56.34 /

-13 (-18.75%)

  • 09
    Jun
VRM Vroom
$56.34 /

-13 (-18.75%)

VRM Vroom
$56.34 /

-13 (-18.75%)

Hot Stocks
SCWorx appoints Timothy Hannibal as president, COO » 07:14
08/14/20
08/14
07:14
08/14/20
07:14
WORX

SCWorx

$2.33 /

+0.27 (+13.11%)

SCWorx announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WORX SCWorx
$2.33 /

+0.27 (+13.11%)

WORX SCWorx
$2.33 /

+0.27 (+13.11%)

WORX SCWorx
$2.33 /

+0.27 (+13.11%)

Recommendations
NetEase price target raised to $520 from $435 at Benchmark » 07:13
08/14/20
08/14
07:13
08/14/20
07:13
NTES

NetEase

$464.95 /

-9.21 (-1.94%)

Benchmark analyst Fawne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTES NetEase
$464.95 /

-9.21 (-1.94%)

NTES NetEase
$464.95 /

-9.21 (-1.94%)

07/27/20 Barclays
NetEase price target raised to $500 from $450 at Barclays
07/21/20 Citi
NetEase price target raised to $543 from $453 at Citi
06/12/20
Fly Intel: Top five analyst initiations
06/11/20 Goldman Sachs
NetEase initiated with a Buy at Goldman Sachs
NTES NetEase
$464.95 /

-9.21 (-1.94%)

NTES NetEase
$464.95 /

-9.21 (-1.94%)

NTES NetEase
$464.95 /

-9.21 (-1.94%)

NTES NetEase
$464.95 /

-9.21 (-1.94%)

Downgrade
New Relic downgraded to Hold from Buy at Argus » 07:13
08/14/20
08/14
07:13
08/14/20
07:13
NEWR

New Relic

$55.78 /

+1.25 (+2.29%)

Argus analyst Joseph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NEWR New Relic
$55.78 /

+1.25 (+2.29%)

NEWR New Relic
$55.78 /

+1.25 (+2.29%)

08/05/20 UBS
New Relic sales turnaround taking longer than expected, says UBS
08/05/20 JPMorgan
New Relic downgraded to Neutral on strategy change at JPMorgan
08/05/20 JPMorgan
New Relic downgraded to Neutral from Overweight at JPMorgan
08/04/20 BMO Capital
New Relic price target raised to $78 from $70 at BMO Capital
NEWR New Relic
$55.78 /

+1.25 (+2.29%)

NEWR New Relic
$55.78 /

+1.25 (+2.29%)

Hot Stocks
BioXcel Therapeutics sees cash runway well into 2022 » 07:12
08/14/20
08/14
07:12
08/14/20
07:12
BTAI

BioXcel Therapeutics

$44.71 /

+0.45 (+1.02%)

In July 2020, the Company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BTAI BioXcel Therapeutics
$44.71 /

+0.45 (+1.02%)

BTAI BioXcel Therapeutics
$44.71 /

+0.45 (+1.02%)

07/21/20 Canaccord
BioXcel Therapeutics price target raised to $120 from $71 at Canaccord
07/20/20 BMO Capital
BioXcel Therapeutics price target raised to $104 from $64 at BMO Capital
07/20/20 H.C. Wainwright
BioXcel Therapeutics price target raised to $200 from $120 at H.C. Wainwright
07/08/20 H.C. Wainwright
BioXcel Therapeutics price target raised to $120 from $95 at H.C. Wainwright
BTAI BioXcel Therapeutics
$44.71 /

+0.45 (+1.02%)

  • 29
    Jul
  • 20
    Feb
  • 26
    Sep
BTAI BioXcel Therapeutics
$44.71 /

+0.45 (+1.02%)

Upgrade
Tapestry upgraded to Outperform from In Line at Evercore ISI » 07:12
08/14/20
08/14
07:12
08/14/20
07:12
TPR

Tapestry

$15.42 /

-0.15 (-0.96%)

Evercore ISI analyst Omar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TPR Tapestry
$15.42 /

-0.15 (-0.96%)

TPR Tapestry
$15.42 /

-0.15 (-0.96%)

07/27/20
Fly Intel: Top five analyst upgrades
07/27/20 Goldman Sachs
Tapestry upgraded to Buy from Neutral at Goldman Sachs
05/07/20
Fly Intel: Top five analyst upgrades
05/07/20 HSBC
Tapestry upgraded to Buy from Hold at HSBC
TPR Tapestry
$15.42 /

-0.15 (-0.96%)

TPR Tapestry
$15.42 /

-0.15 (-0.96%)

TPR Tapestry
$15.42 /

-0.15 (-0.96%)

TPR Tapestry
$15.42 /

-0.15 (-0.96%)

Hot Stocks
BioXcel expects data from Phase 1b/2 study of BXCL701 later this year » 07:12
08/14/20
08/14
07:12
08/14/20
07:12
BTAI

BioXcel Therapeutics

$44.71 /

+0.45 (+1.02%)

The Phase 2 portion of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BTAI BioXcel Therapeutics
$44.71 /

+0.45 (+1.02%)

BTAI BioXcel Therapeutics
$44.71 /

+0.45 (+1.02%)

07/21/20 Canaccord
BioXcel Therapeutics price target raised to $120 from $71 at Canaccord
07/20/20 BMO Capital
BioXcel Therapeutics price target raised to $104 from $64 at BMO Capital
07/20/20 H.C. Wainwright
BioXcel Therapeutics price target raised to $200 from $120 at H.C. Wainwright
07/08/20 H.C. Wainwright
BioXcel Therapeutics price target raised to $120 from $95 at H.C. Wainwright
BTAI BioXcel Therapeutics
$44.71 /

+0.45 (+1.02%)

  • 29
    Jul
  • 20
    Feb
  • 26
    Sep
BTAI BioXcel Therapeutics
$44.71 /

+0.45 (+1.02%)

Upgrade
Qiagen upgraded to Outperform from Neutral at Exane BNP Paribas » 07:11
08/14/20
08/14
07:11
08/14/20
07:11
QGEN

Qiagen

$48.66 /

+0.24 (+0.50%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QGEN Qiagen
$48.66 /

+0.24 (+0.50%)

QGEN Qiagen
$48.66 /

+0.24 (+0.50%)

03/04/20 Stifel
Qiagen deal a positive for Thermo Fisher, says Stifel
03/04/20 Berenberg
Qiagen downgraded to Hold from Buy at Berenberg
03/03/20 Piper Sandler
Danaher unlikely to make competing bid for Qiagen, says Piper Sandler
02/05/20 Piper Sandler
Qiagen price target raised to $36 from $29 at Piper Sandler
QGEN Qiagen
$48.66 /

+0.24 (+0.50%)

QGEN Qiagen
$48.66 /

+0.24 (+0.50%)

QGEN Qiagen
$48.66 /

+0.24 (+0.50%)

QGEN Qiagen
$48.66 /

+0.24 (+0.50%)

Recommendations
Rapt Therapeutics price target raised to $40 from $35 at BMO Capital » 07:11
08/14/20
08/14
07:11
08/14/20
07:11
RAPT

Rapt Therapeutics

$22.70 /

+0.16 (+0.71%)

BMO Capital analyst Do…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RAPT Rapt Therapeutics
$22.70 /

+0.16 (+0.71%)

RAPT Rapt Therapeutics
$22.70 /

+0.16 (+0.71%)

07/27/20 Cantor Fitzgerald
Rapt Therapeutics price target raised to $51 from $37 at Cantor Fitzgerald
07/13/20 Wells Fargo
Rapt Therapeutics price target raised to $40 from $33 at Wells Fargo
06/01/20 H.C. Wainwright
Rapt Therapeutics initiated with a Buy at H.C. Wainwright
05/19/20
Fly Intel: Top five analyst initiations
RAPT Rapt Therapeutics
$22.70 /

+0.16 (+0.71%)

  • 07
    Feb
  • 31
    Oct
Hot Stocks
BioXcel Therapeutics plans to submit NDA for BXCL501 in 1Q21 » 07:11
08/14/20
08/14
07:11
08/14/20
07:11
BTAI

BioXcel Therapeutics

$44.71 /

+0.45 (+1.02%)

In July 2020, BTI…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BTAI BioXcel Therapeutics
$44.71 /

+0.45 (+1.02%)

BTAI BioXcel Therapeutics
$44.71 /

+0.45 (+1.02%)

07/21/20 Canaccord
BioXcel Therapeutics price target raised to $120 from $71 at Canaccord
07/20/20 BMO Capital
BioXcel Therapeutics price target raised to $104 from $64 at BMO Capital
07/20/20 H.C. Wainwright
BioXcel Therapeutics price target raised to $200 from $120 at H.C. Wainwright
07/08/20 H.C. Wainwright
BioXcel Therapeutics price target raised to $120 from $95 at H.C. Wainwright
BTAI BioXcel Therapeutics
$44.71 /

+0.45 (+1.02%)

  • 29
    Jul
  • 20
    Feb
  • 26
    Sep
BTAI BioXcel Therapeutics
$44.71 /

+0.45 (+1.02%)

Recommendations
Applied Materials price target raised to $80 from $75 at Wells Fargo » 07:11
08/14/20
08/14
07:11
08/14/20
07:11
AMAT

Applied Materials

$65.02 /

-1.5 (-2.25%)

Wells Fargo analyst Joe…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMAT Applied Materials
$65.02 /

-1.5 (-2.25%)

AMAT Applied Materials
$65.02 /

-1.5 (-2.25%)

06:59 Today Susquehanna
Applied Materials price target raised to $85 from $74 at Susquehanna
06:53 Today Stifel
Applied Materials price target raised to $85 from $75 at Stifel
05:45 Today Stifel
KLA Corp, ACM likely beneficiaries after Applied Materials earnings, says Stifel
08/11/20 Wells Fargo
Applied Materials price target raised to $75 from $70 at Wells Fargo
AMAT Applied Materials
$65.02 /

-1.5 (-2.25%)

AMAT Applied Materials
$65.02 /

-1.5 (-2.25%)

AMAT Applied Materials
$65.02 /

-1.5 (-2.25%)

AMAT Applied Materials
$65.02 /

-1.5 (-2.25%)

Earnings
BioXcel Therapeutics reports Q2 EPS ($1.06), consensus (75c) » 07:09
08/14/20
08/14
07:09
08/14/20
07:09
BTAI

BioXcel Therapeutics

$44.71 /

+0.45 (+1.02%)

"Since inception,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BTAI BioXcel Therapeutics
$44.71 /

+0.45 (+1.02%)

BTAI BioXcel Therapeutics
$44.71 /

+0.45 (+1.02%)

07/21/20 Canaccord
BioXcel Therapeutics price target raised to $120 from $71 at Canaccord
07/20/20 BMO Capital
BioXcel Therapeutics price target raised to $104 from $64 at BMO Capital
07/20/20 H.C. Wainwright
BioXcel Therapeutics price target raised to $200 from $120 at H.C. Wainwright
07/08/20 H.C. Wainwright
BioXcel Therapeutics price target raised to $120 from $95 at H.C. Wainwright
BTAI BioXcel Therapeutics
$44.71 /

+0.45 (+1.02%)

  • 29
    Jul
  • 20
    Feb
  • 26
    Sep
BTAI BioXcel Therapeutics
$44.71 /

+0.45 (+1.02%)

Upgrade
Dassault Systemes upgraded to Buy from Neutral at Redburn » 07:08
08/14/20
08/14
07:08
08/14/20
07:08
DASTY

Dassault Systemes

$0.00 /

+ (+0.00%)

Redburn analyst Neil…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DASTY Dassault Systemes
$0.00 /

+ (+0.00%)

DASTY Dassault Systemes
$0.00 /

+ (+0.00%)

07/24/20 JPMorgan
Dassault Systemes price target raised to EUR 165 from EUR 150 at JPMorgan
07/24/20 Deutsche Bank
Deutsche Bank backs Hold on Dassault after Q2 results
07/24/20 UBS
UBS backs Sell on Dassault after Q2 results
07/24/20 Barclays
Dassault Systemes delivered 'resilient' quarter, says Barclays
Hot Stocks
Imara expects cash to be sufficient to fund operations into mid-2022 » 07:07
08/14/20
08/14
07:07
08/14/20
07:07
IMRA

Imara

$20.13 /

-0.46 (-2.23%)

The Company currently…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMRA Imara
$20.13 /

-0.46 (-2.23%)

IMRA Imara
$20.13 /

-0.46 (-2.23%)

06/30/20 Citi
Imara downgraded to Neutral from Buy at Citi
04/07/20 Citi
Imara initiated with a Buy at Citi
04/06/20
Fly Intel: Top five analyst initiations
04/06/20 Morgan Stanley
Imara initiated with an Overweight at Morgan Stanley
IMRA Imara
$20.13 /

-0.46 (-2.23%)

  • 12
    Mar
IMRA Imara
$20.13 /

-0.46 (-2.23%)

Hot Stocks
e.l.f. Cosmetics launches 'first-ever' TikTok reality show » 07:07
08/14/20
08/14
07:07
08/14/20
07:07
ELF

e.l.f. Beauty

$20.15 /

+0.05 (+0.25%)

, TWTR

Twitter

$37.82 /

+0.375 (+1.00%)

, MSFT

Microsoft

$208.71 /

-0.56 (-0.27%)

e.l.f. Beauty (ELF) said…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ELF e.l.f. Beauty
$20.15 /

+0.05 (+0.25%)

TWTR Twitter
$37.82 /

+0.375 (+1.00%)

MSFT Microsoft
$208.71 /

-0.56 (-0.27%)

ELF e.l.f. Beauty
$20.15 /

+0.05 (+0.25%)

08/06/20 Truist
e.l.f. Beauty price target raised to $25 from $20 at Truist
07/16/20 JPMorgan
e.l.f. Beauty price target raised to $22 from $17 at JPMorgan
07/15/20 Piper Sandler
e.l.f. Beauty price target raised to $25 from $20 at Piper Sandler
06/25/20 Morgan Stanley
e.l.f. Beauty target raised to $22 at Morgan Stanley as scanner data outperforms
TWTR Twitter
$37.82 /

+0.375 (+1.00%)

07/28/20 Morgan Stanley
Morgan Stanley lowers near-term, long-term forecasts for Roku
07/24/20 SunTrust
Twitter price target raised to $40 from $32 at SunTrust
07/24/20 Argus
Twitter price target raised to $46 from $40 at Argus
07/24/20 Canaccord
Twitter price target raised to $40 from $32 at Canaccord
MSFT Microsoft
$208.71 /

-0.56 (-0.27%)

08/07/20 DA Davidson
Datadog price target raised to $80 from $52 at DA Davidson
08/05/20 Morgan Stanley
Morgan Stanley says TikTok US operations could be 'compelling' fit for Microsoft
08/04/20 Wedbush
Wedbush sees 75%-80% chance of Microsoft buying TikTok's U.S. operations
08/04/20 Oppenheimer
TikTok presents 'unique opportunity' for Microsoft, says Oppenheimer
ELF e.l.f. Beauty
$20.15 /

+0.05 (+0.25%)

TWTR Twitter
$37.82 /

+0.375 (+1.00%)

MSFT Microsoft
$208.71 /

-0.56 (-0.27%)

  • 03
    Dec
  • 29
    Aug
ELF e.l.f. Beauty
$20.15 /

+0.05 (+0.25%)

TWTR Twitter
$37.82 /

+0.375 (+1.00%)

MSFT Microsoft
$208.71 /

-0.56 (-0.27%)

ELF e.l.f. Beauty
$20.15 /

+0.05 (+0.25%)

TWTR Twitter
$37.82 /

+0.375 (+1.00%)

MSFT Microsoft
$208.71 /

-0.56 (-0.27%)

ELF e.l.f. Beauty
$20.15 /

+0.05 (+0.25%)

TWTR Twitter
$37.82 /

+0.375 (+1.00%)

MSFT Microsoft
$208.71 /

-0.56 (-0.27%)

MSFT Microsoft
$208.71 /

-0.56 (-0.27%)

Initiation
Altimmune initiated with an Outperform at Evercore ISI » 07:07
08/14/20
08/14
07:07
08/14/20
07:07
ALT

Altimmune

$23.71 /

+1.18 (+5.24%)

Evercore ISI analyst Josh…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALT Altimmune
$23.71 /

+1.18 (+5.24%)

ALT Altimmune
$23.71 /

+1.18 (+5.24%)

08/04/20 Piper Sandler
Merck deal sparks interest in GLP-1:glucagon agonists, says Piper Sandler
07/31/20
Fly Intel: Top five analyst initiations
07/30/20 Piper Sandler
Altimmune initiated with an Overweight at Piper Sandler
07/28/20 JMP Securities
Altimmune initiated with an Outperform at JMP Securities
ALT Altimmune
$23.71 /

+1.18 (+5.24%)

  • 14
    Jul
ALT Altimmune
$23.71 /

+1.18 (+5.24%)

ALT Altimmune
$23.71 /

+1.18 (+5.24%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.